NASDAQ: MLTX · Biotechnology
Over the past week, MoonLake Immunotherapeutics (MLTX) drew about 59 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 49% bullish across the tracked sources. Wall Street is more constructive, with 11 of 15 analysts rating MLTX a buy.
There is steady buzz around MLTX this week and broad agreement on direction, which is why it reads as a Hold.
Wall Street’s 73% buy share sits next to a crowd that ranges from X at 47% to News at 50%. No other tracker puts the two side by side.
15 analysts have weighed in: a Strong Buy consensus: 11 buy calls against 2 sell, with an average 12-month price target of $28.54.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits right on the neutral line, momentum is improving and the 2 sources broadly agree, so the read is Hold rather than a clear buy or sell.
Analysts sit 24 points above the crowd average of 49%, the professionals are more constructive than retail. The split is inside the crowd: News reads 50% bullish while X sits at 47%, a 3-point spread that single-source trackers miss.
Over the 30-day window, MoonLake Immunotherapeutics (MLTX) buzz held subdued around 32.5 while the price drifted down 16.3% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.2M shares. Updated Aug 15, 2026. Over the last 7 trading days, MLTX lost 8.7%. Buzz activity in the recent week averaged 34.1 and was highly volatile, swinging between 14.0 and 59.8. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 7 of the 11 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Reddit data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for MLTX and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live MLTX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (11 / 2 / 2) |
| Crowd bullish (7d) | 49% |
| Avg price target | $28.54 |
| Most bullish source | News, 50% |
| Most bearish source | X, 47% |
| Sentiment spread | 3 pts |
| Mentions (7d) | 59 |
| Market cap | $1.4B |
| EPS · Beta | -$3.84 · 1.1 |
| Industry | Biotechnology |
Based on aggregated sentiment from X and News sources, MoonLake Immunotherapeutics (MLTX) currently carries an Adanos hold signal with 69/100 conviction. The current cross-source average reads 49% bullish across 2 active sources. Those sources contribute 59 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
The crowd reads split on MoonLake Immunotherapeutics (MLTX), averaging 49% bullish across 2 tracked sources over the last 7 days. The two ends of the range are News at 50% bullish and X at 47%, a 3-point spread. On the professional side, 11 of 15 analysts rate MLTX a buy.
Of the 15 analysts covering MoonLake Immunotherapeutics (MLTX), 11 rate it a buy, 2 a hold and 2 a sell, for a strong buy consensus. The average price target is $28.54. That puts the street ahead of the crowd, which averages 49% bullish.
MoonLake Immunotherapeutics (MLTX)'s cross-source average is mixed at 49% bullish. Source readings are split: 1 source leans bearish and 1 source sits at 50% bullish. News reads 50% bullish and x coverage is the most negative at 47% bullish. The combined signal points to broad mixed pressure with 69/100 conviction.
The cross-source average is mixed for MoonLake Immunotherapeutics (MLTX) at 49% bullish. Source readings are split: 1 source leans bearish and 1 source sits at 50% bullish. The most bearish reading is x at 47% bullish. 3-day activity momentum is rising across X and News. The hold signal carries 69/100 conviction.
X is the dominant discussion channel with 49 mentions (83% of total volume). News contributes 10 mentions. The cross-source average is mixed at 49% bullish, while x and news show rising 3-day activity. Source readings are split: 1 source leans bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. MLTX's hold signal at 69/100 conviction reflects a mixed cross-source average at 49% bullish. Source readings are split: 1 source leans bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The MLTX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key